Cyclosporine: What Clinicians Need to Know - 22/06/18
Doi : 10.1016/S0733-8635(18)30052-4
John Koo, MD a, ⁎, Jaeho Lee, MD b
a From the Psoriasis Treatment Center and Phototherapy Unit, Dermatology Drug Research Unit, Psychodermatology Clinic, University of California San Francisco Medical Center, San Francisco, California
b The Department of Dermatology, University of California San Francisco Medical Center, San Francisco, California
*Address reprint requests to: John Koo, MD, Psychodermatology Clinic, University of California San Francisco Medical Center, 515 Spruce Street, San Francisco, CA 94118Psychodermatology ClinicUniversity of California San Francisco Medical Center515 Spruce StreetSan FranciscoCA94118
Résumé |
It is well established that cyclosporin A is effective in the treatment of psoriasis and many other dermatologic conditions. In this article, recommendations regarding the optimal use of cyclosporine for the treatment of psoriasis are presented with an emphasis on information that will be relevent for the average clinician. In addition to the most important issues, such as dosage, side effects, patient selection, and so forth, the article also covers pharmocokinetics and contains a brief section on mechanisms of action.
Le texte complet de cet article est disponible en PDF.© 1995
Elsevier Inc. Tous droits réservés.
Vol 13 - N° 4
P. 897-907 - octobre 1995 Retour au numéro
Article précédent
- Systemic Retinoids for Psoriasis
- Joshua M. Wieder, Nicholas J. Lowe
- Antimicrobial Treatment of Psoriasis
- Robert B. Skinner, E. William Rosenberg, Patricia W. Noah
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?